Ebiratide triacetate | CAS# 115994-46-2 | Biochemical

MedKoo Cat#: 576340 | Name: Ebiratide triacetate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Ebiratide triacetate is an adrenocorticotropic hormone (ACTH) analogue.

Chemical Structure

Ebiratide triacetate

CAS#115994-46-2

Theoretical Analysis

MedKoo Cat#: 576340

Name: Ebiratide triacetate

CAS#: 115994-46-2

Chemical Formula: C54H85N11O16S

Exact Mass: 1175.5896

Molecular Weight: 1176.39

Elemental Analysis: C, 55.13; H, 7.28; N, 13.10; O, 21.76; S, 2.73

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Ebiratide triacetate; HOE-427 triacetate; HOE 427 triacetate; HOE427 triacetate

IUPAC/Chemical Name

L-Phenylalaninamide, (2S)-2-amino-4-(methylsulfonyl)butanoyl-L-alpha-glutamyl-L-histidyl-L-phenylalanyl-D-lysyl-Nalpha-(8-aminooctyl)-, triacetate

InChi Key

DJSBOBHLKLQPRK-KBHHYMAYSA-N

InChi Code

InChI=1S/C48H73N11O10S.3C2H4O2/c1-70(68,69)27-23-36(51)44(63)55-37(21-22-42(60)61)45(64)58-40(30-35-31-53-32-54-35)47(66)57-39(28-33-16-8-6-9-17-33)46(65)56-38(20-12-14-25-50)48(67)59(26-15-5-3-2-4-13-24-49)41(43(52)62)29-34-18-10-7-11-19-34;3*1-2(3)4/h6-11,16-19,31-32,36-41H,2-5,12-15,20-30,49-51H2,1H3,(H2,52,62)(H,53,54)(H,55,63)(H,56,65)(H,57,66)(H,58,64)(H,60,61);3*1H3,(H,3,4)/t36-,37-,38+,39-,40-,41-;;;/m0.../s1

SMILES Code

CC(=O)O.CC(=O)O.CC(=O)O.CS(=O)(=O)CC[C@H](N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](CCCCN)C(=O)N(CCCCCCCCN)[C@@H](Cc3ccccc3)C(=O)N

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

To be determined

Shelf Life

>2 years if stored properly

Drug Formulation

To be determined

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 1,176.39 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1. Terasaki T, Takakuwa S, Saheki A, Moritani S, Shimura T, Tabata S, Tsuji A. Absorptive-mediated endocytosis of an adrenocorticotropic hormone (ACTH) analogue, ebiratide, into the blood-brain barrier: studies with monolayers of primary cultured bovine brain capillary endothelial cells. Pharm Res. 1992 Apr;9(4):529-34. doi: 10.1023/a:1015848531603. PMID: 1323100.